Recombinant Interferon Alpha

DRUG2 trials

Sponsors

Institute of Hematology & Blood Diseases Hospital, China

Conditions

Essential Thrombocytopenia

Phase 2

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

RecruitingNCT04226950

Institute of Hematology & Blood Diseases Hospital, ChinaEssential Thrombocytopenia

Start: 2020-01-10End: 2024-11-20Target: 40Updated: 2024-07-03

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia

Institute of Hematology & Blood Diseases Hospital, ChinaEssential Thrombocytopenia

Start: 2022-06-01End: 2025-06-30Target: 194Updated: 2024-07-03